SCIMECA, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 1.129
EU - Europa 660
AS - Asia 210
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.001
Nazione #
US - Stati Uniti d'America 1.123
UA - Ucraina 179
IT - Italia 141
FI - Finlandia 124
CN - Cina 110
SG - Singapore 60
GB - Regno Unito 50
IE - Irlanda 47
DE - Germania 38
SE - Svezia 24
RU - Federazione Russa 21
KR - Corea 19
IN - India 16
FR - Francia 13
BE - Belgio 12
CA - Canada 6
CH - Svizzera 3
HK - Hong Kong 3
NL - Olanda 3
AZ - Azerbaigian 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EU - Europa 1
GR - Grecia 1
LT - Lituania 1
NO - Norvegia 1
TW - Taiwan 1
Totale 2.001
Città #
Chandler 136
Woodbridge 106
Jacksonville 100
Houston 89
Fairfield 86
Ashburn 78
Ann Arbor 63
Wilmington 52
Singapore 50
Dublin 47
Medford 37
Seattle 34
Nanjing 31
Cambridge 29
Princeton 25
Tulsa 24
Seongnam 18
Boardman 16
Kumar 15
Palermo 15
Venice 15
Santa Clara 14
Altamura 12
Beijing 12
Brussels 12
Nanchang 11
Tianjin 10
Dearborn 9
Ludwigshafen am Rhein 9
Des Moines 8
Lawrence 8
Milan 8
New York 8
San Diego 8
Shenyang 7
Changsha 6
Los Angeles 6
San Mateo 6
Auburn Hills 5
Hebei 5
Saint Petersburg 5
Lanzhou 4
Ningbo 4
San Paolo di Civitate 4
West Chicago 4
Central District 3
Charlotte 3
Frankfurt am Main 3
London 3
Marcon 3
Napoli 3
Norwalk 3
Den Haag 2
Edinburgh 2
Falls Church 2
Hangzhou 2
Helsinki 2
Jiaxing 2
Jinan 2
Moscow 2
Orange 2
Phoenix 2
Salerno 2
Shanghai 2
Shaoxing 2
Zhengzhou 2
Abidjan 1
Baku 1
Catania 1
Changchun 1
Chiswick 1
Columbus 1
Düsseldorf 1
Forest City 1
Guangzhou 1
Haikou 1
Indiana 1
Jieyang 1
Jinhua 1
Laojunmiao 1
Leawood 1
Mumbai 1
Oslo 1
Prague 1
Redwood City 1
Seoul 1
Siena 1
Sofia 1
Stockholm 1
Taipei 1
Taiyuan 1
Verona 1
Washington 1
Wuhan 1
Zurich 1
Totale 1.329
Nome #
Incidence of Crohn's disease and Card 15 mutation in a small township in Sicily 139
Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in post-operative Crohn's disease 128
Meta-analysis: remission and response from control arms of randomized trials of biological therapies for active luminal Crohn's disease. 122
EFFICACY AND SAFETY OF ENDOSCOPIC BALLOON DILATION OF SYMPTOMATIC INTESTINAL CROHN'S DISEASE STRICTURES 118
Clinical course of ulcerative colitis 118
MINIMIZING INFLIXIMAB TOXICITY IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE 115
Infliximab in the treatment of Crohn's disease :predictors of response in an Italian multicenter open study 95
The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn's disease: a comparison with ultrasound 90
Calprotectin in the prediction of endoscopic post-surgical recurrence in CD 87
THE ROLE OF CARD15 MUTATIONS AND SMOKING IN THE COURSE OF DISEASE IN A MEDITERRANEAN AREA 86
The role of NOD2/CARD15 mutation and smoking in the course of Crohn's disease in a Mediterranean area 71
Long term follow-up in an incident cohort of 583 pts with CD 71
Infliximab in moderate to severe sateroid dipendent or refractory severe ulcerative colitis:short term results of 21 case treated 69
Infliximab in the treatment of steroid resistant dependant and fistulating crohn's disease:an analysis of predictors of response in an italian multicenter open study in 573 pts 67
Ultrasound in Crohn's disease 66
Occul Hepatitis B and infliximab induced HBV reactivation 65
Le malattie infiammatorie dell'intestino 64
Salycilate in the prevention of post-surgical recurrence in Crohn's disease 63
Il decorso clinico della colite ulcerosa 62
a meta-analysis of the placebo rate of clinical relapse and severe endoscopic recurrence in post-operative maintenance therapy in Crohn's disease 62
efficacy and safety of endoscopic ballon dilatation of symptomatic gastrointestinal Crohn's disease strictures 60
NOD2/CARD15 FREQUENCY IN CROHN'DISEASE IN SICILY:AN EPIDEMIOLOGICAL STUDY 58
a metaregression analysis of the placebo rates of remission and response in clinical trials of biological therapies in active crohn's disease 57
Come limitare la tossicità dell'infliximab 53
Infliximab in the treatment of steroid resistant dependant and fistulating crohn's disease:an analysis of predictors of response in an italian multicenter open study in 573 pts 41
Totale 2.027
Categoria #
all - tutte 7.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.450


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020264 0 0 0 0 42 53 48 13 49 10 21 28
2020/2021278 6 36 12 29 29 6 25 8 45 20 30 32
2021/2022205 7 63 3 6 2 6 8 8 25 25 8 44
2022/2023311 27 46 6 34 47 48 6 33 46 1 16 1
2023/2024113 9 36 5 7 9 22 9 2 0 3 0 11
2024/202598 5 30 22 39 2 0 0 0 0 0 0 0
Totale 2.027